Almost two thirds of patients with T-cell acute lymphoblastic leukaemia involved in a clinical trial of the treatment are now disease-free.

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL and Great Ormond Street Hospital (GOSH), has shown promising results in helping children and adults ...